An Alternative Way to Classify Missing Data Mechanism in Clinical Trials—A Dialogue on Missing Data

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.21, Iss.2, 2011-03, pp. : 355-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Missing Data in Confirmatory Clinical Trials

By Flyer Paul Hirman Joseph

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 969-979

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Inaction: Preventing Missing Outcome Data in Randomized Clinical Trials

By Wittes Janet

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 957-968

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials

By Denne J. S. Stone A. M. Bailey-Iacona R. Chen T.-T.

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 951-970

Taylor & Francis Ltd

Access to resources Recommend Favorite

An Overview of Practical Approaches for Handling Missing Data in Clinical Trials

By DeSouza Cynthia Legedza Anna Sankoh Abdul

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 1055-1073

Taylor & Francis Ltd

Access to resources Recommend Favorite

Handling Missing Data in Vaccine Clinical Trials for Immunogenicity and Safety Evaluation

By Li Xiaoming Wang William Liu Guanghan Chan Ivan

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 2, 2011-03 ,pp. : 294-310

Taylor & Francis Ltd

Access to resources Recommend Favorite